Xeris Biopharma Holdings, Inc. XERS
XERS
Xeris Biopharma Holdings, Inc. PLX
Protalix BioTherapeutics, Inc. MCRB
Seres Therapeutics, Inc. CDTX
Cidara Therapeutics, Inc. IBRX
ImmunityBio, Inc. GRTX
Galera Therapeutics, Inc. MREO
Mereo BioPharma Group plc TERN
Terns Pharmaceuticals, Inc. PDSB
PDS Biotechnology Corporation INZY
Inozyme Pharma, Inc.
Xeris Biopharma Holdings, Inc. PLX
Protalix BioTherapeutics, Inc. MCRB
Seres Therapeutics, Inc. CDTX
Cidara Therapeutics, Inc. IBRX
ImmunityBio, Inc. GRTX
Galera Therapeutics, Inc. MREO
Mereo BioPharma Group plc TERN
Terns Pharmaceuticals, Inc. PDSB
PDS Biotechnology Corporation INZY
Inozyme Pharma, Inc.
Performance
| Periode | XERS | PLX | MCRB | CDTX | IBRX | GRTX | MREO | TERN | PDSB | INZY |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 92.07 % | -2.07 % | 61.90 % | 521.15 % | -10.27 % | -27.08 % | 0.51 % | 280.84 % | -8.03 % | 177.78 % |
| YTD | 130.92 % | 19.80 % | 13.34 % | 314.10 % | -8.17 % | -56.36 % | -42.69 % | 43.74 % | -45.24 % | 40.35 % |
| 1Y | 169.02 % | 122.64 % | 14.35 % | 997.57 % | -36.56 % | -74.26 % | -56.15 % | 6.96 % | -71.12 % | -31.03 % |
| 3Y | 519.38 % | 129.15 % | -86.54 % | 855.62 % | -54.44 % | -98.92 % | 94.06 % | 15.60 % | -76.49 % | 17.99 % |
| 5Y | 51.61 % | -36.56 % | -97.21 % | 89.68 % | -75.00 % | -99.86 % | -10.91 % | -55.68 % | -61.65 % | -79.54 % |
| 10Y | -60.48 % | -78.55 % | -96.71 % | -60.14 % | -80.03 % | -99.85 % | -69.85 % | -55.68 % | -99.79 % | -77.19 % |
| From the beginning | -60.48 % | -99.72 % | -98.14 % | -64.67 % | -93.19 % | -99.85 % | -69.85 % | -55.68 % | -99.57 % | -77.19 % |